Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1β and is mediated by the interleukin-4 receptor α-chain

American Journal of Respiratory and Critical Care Medicine

Volumn 165, Issue 8, 2002, Pages 1161-1171

  Hirst, Stuart J ^a   Hallsworth, Matthew P ^a   Peng, Qi ^a   Lee, Tak H ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Airway smooth muscle; Asthma; Cytokine receptors; Cytokines; Eotaxin

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NEUTRALIZING ANTIBODY; RANTES; STAT6 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; ATOPY; BRONCHUS HYPERREACTIVITY; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

EID: 0037090417     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.165.8.2107158     Document Type: Article

References (60)

1. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines
2. Cultured human airway smooth muscle cells stimulated by interleukin-1β enhance eosinophil survival
3. Tumor necrosis factor-α enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells
4. Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: Suppression by dexamethasone
5. Expression and release of interleukin-8 by human airway smooth muscle cells: Inhibition by Th-2 cytokines and corticosteroids
6. Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1β and TNFα: Effects of IL-10 and corticosteroids
7. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle
8. Synthetic functions of airway smooth muscle in asthma
9. Airway smooth muscle cells: Contributing to and regulating airway mucosal inflammation?
10. Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines
11. Chemokines and tissue injury
12. Upregulation of formyl-peptide- and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma
13. Interleukin-8 is a potent eosinophil chemoattractant
14. Cloning of the human eosinophil chemoattractant, eotaxin: Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils
15. Recombinant human granulocyte-macrophage colony stimulating factor stimulates in vitro mature neutrophil and eosinophil function, surface receptor expression and survival
16. Interleukin (IL)-4-independent induction of immunoglobulin (Ig) E, and perturbation of T cell development in transgenic mice expressing IL-13
17. IL-13 selectively induces cell adhesion molecule-1 expression in human endothelial cells
18. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
19. Interleukin-13: Central mediator of allergic asthma
20. Elevated expression of messenger ribonucleic acid encoding IL-I3 in bronchial mucosa of atopic and non-atopic subjects with asthma
21. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma
22. IL-13 expression at the sites of allergen challenge in patients with asthma
23. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis physiologic abnormalities, and eotaxin production
24. Airway smooth muscle cell culture: Application to studies of airway wall remodeling and phenotype plasticity in asthma
25. 2-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells
26. Inhibitors of MAP kinases differentially regulated eosinophil-activating cytokine release from human airway smooth muscle
27. Signal transduction via the IL-4 receptor and its correlation with atopy
28. The IL-4/IL-13 signaling pathway
29. Interleukin-4 inhibits mitogen-induced proliferation of human airway smooth muscle
30. Expression of monocyte chemotactic protein (MCP)-1, MCP-2 and MCP-3 by human airway smooth muscle
31. T cells and cytokines in bronchoalveolar lavage fluid after segmental allergen challenge in atopic asthma
32. Activation of CD4+ T cells, increased Th2 cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
33. Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late phase cutaneous reactions in atopic subjects
34. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
35. Increases in activated T cells, eosinophils, and cytokine mRNA expression for interleukin-5, granulocyte/macrophage colony-stimulating factor, in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
36. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts
37. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1β on production of IL-1 receptor antagonist by human primary heptaocytes and hepatoma HepG2 cells: Differential effect of C-reactive protein production
38. Tumour necrosis factor alpha enhances the expression of the interleukin (IL)-4 receptor alpha-chain on endothelial cells increasing IL-4 or IL-13-induced STAT6 activation
39. Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and STAT6 activation
40. Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-α on eosinophil activation in vitro
41. Synergistic induction of eotaxin expression in human keratocytes by TNF-α and IL-4 or IL-13
42. Chemokine production by BEAS-2B human bronchial epithelial cells: Differential regulation of eotaxin, IL-8, and RANTES by Th2- and Th1-derived cytokines
43. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells
44. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
45. Human interleukin-4 receptor confers biological responsiveness and defines a novel superfamily
46. The IL-4 receptor: Signaling mechanisms and biologic functions
47. The role of IL-13 and its receptor in allergy and inflammatory responses
48. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex
49. Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells
50. Protein tyrosine phosphatase activity is required for IL-4 induction of IL-4 receptor α-chain
51. Up-regulation of IL-4/B-cell stimulatory factor-1 receptor expression
52. Cloning of murine STAT6 and human STAT6, STAT proteins that are tyrosine phosphorylated in response to IL-4 and IL-13 but are not required for mitogenesis
53. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice
54. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice
55. STAT6 mediates eotaxin-1 expression in IL-4 or TNT-alpha-induced fibroblasts
56. Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells
57. Multiple signaling pathways mediate IL-4-induced 3β-hydroxysteroid dehydrogenase/δ5-δ4 isomerase type 1 gene expression in human breast cancer cells
58. IL-4 regulation of IL-6 production involves Rac/Cdc42- and p38 MAPK-dependent pathways in keratinocytes
59. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes
60. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target for interleukin (IL)-4 and IL-10 anti-inflammatory action